Last updated: January 8, 2022
Sponsor: Radboud University
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT05189964
THA&PA
Ages 16-50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The age of the patient is between 16 and 50 years.
- The patient has an indication for primary THA.
Exclusion
Exclusion Criteria:
- Patients with an underlying oncologic disease which results in THA.
- Patients who are not able to walk.
Study Design
Total Participants: 90
Study Start date:
December 01, 2021
Estimated Completion Date:
October 01, 2024
Connect with a study center
Radboudumc
Nijmegen, Gelderland 6525 GA
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.